Circadian genes like PER1 and BMAL1, involved in DNA damage response, may exhibit altered expression in SCLC, potentially affecting the tumor’s response to therapeutic interventions such as radiation and chemotherapy, both of which interact with the circadian control of cell cycle and apoptosis [203]. This evidence concerns the gene BMAL1 and neoplasm.